Varex Imaging (VREX) Non-Current Assets (2016 - 2026)
Varex Imaging's (VREX) quarterly Non-Current Assets came in at $463.8 million in Q2 2026, down 31.17% year-on-year from $673.8 million in Q2 2025, and little changed on a QoQ basis from $464.4 million in Q1 2026.
Varex Imaging (VREX) Non-Current Assets (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has 11 years of Non-Current Assets data on file, last reported at $463.8 million in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 31.17% year-over-year to $463.8 million in Q2 2026; TTM through Apr 2026 was $1.8 billion, a 26.57% decrease from a year earlier, with the FY2025 full-year figure at $465.6 million, down 17.4% from the prior year.
- Non-Current Assets for Q2 2026 stood at $463.8 million, roughly flat from $464.4 million in the prior quarter.
- Over the last five years, Non-Current Assets for VREX reached as high as $675.3 million in Q1 2025 and fell as low as $453.9 million in Q3 2025.
- Historically, Non-Current Assets has averaged $564.0 million across 5 years, with a median of $573.4 million in 2022.
- Across the five-year window, Non-Current Assets climbed 13.19% in 2025 and slumped 31.23% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $573.6 million in 2022, then grew by 4.01% to $596.6 million in 2023, then fell by 5.51% to $563.7 million in 2024, then retreated by 17.4% to $465.6 million in 2025, then fell by 0.39% to $463.8 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $463.8 million in Q2 2026, $464.4 million in Q1 2026, and $465.6 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Varex Imaging | 450.24 Mn | 375.84 Mn | 72.60 Mn | 463.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 463.80 Mn |
| Jan 2, 2026 | 464.40 Mn |
| Oct 3, 2025 | 465.60 Mn |
| Jul 4, 2025 | 453.90 Mn |
| Apr 4, 2025 | 673.80 Mn |
| Jan 3, 2025 | 675.30 Mn |
| Sep 27, 2024 | 563.70 Mn |
| Jun 28, 2024 | 603.40 Mn |
| Mar 29, 2024 | 599.80 Mn |
| Dec 29, 2023 | 596.60 Mn |
| Sep 29, 2023 | 591.30 Mn |
| Jun 30, 2023 | 573.20 Mn |
| Mar 31, 2023 | 572.40 Mn |
| Dec 30, 2022 | 573.60 Mn |
| Sep 30, 2022 | 574.50 Mn |
| Jul 1, 2022 | 570.00 Mn |
| Apr 1, 2022 | 573.40 Mn |
| Dec 31, 2021 | 581.10 Mn |
| Oct 1, 2021 | 593.30 Mn |
| Jul 2, 2021 | 601.10 Mn |